Markets:

Overview

News

Currencies

International

Treasuries

Aytu BioPharma, Inc. - Common Stock (NQ:AYTU)

2.750 -0.150 (-5.17%)

Streaming Delayed Price Updated: 2:45 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aytu BioPharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 13, 2022

Gainers Corbus Pharmaceuticals (NASDAQ:CRBP) shares rose 24.6% to $0.14 during Thursday's pre-market session. The market value of their outstanding shares is at $17.1 million.

Via Benzinga

Aytu BioPharma Announces Strategic Shift to Focus on Commercial Operations and Indefinite Suspension of Clinical Development Programs

October 13, 2022

Via ACCESSWIRE

11 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 05, 2022

Gainers Bionano Genomics (NASDAQ:BNGO) stock increased by 9.8% to $2.24. The company's market cap stands at $649.9 million.

Via Benzinga

Aytu BioPharma Announces Continuing Availability of ADHD Medication Adzenys XR-ODT(R) in Response to Reported Generic Adderall(R) XR Supply Disruptions

October 05, 2022

Via ACCESSWIRE

Aytu BioPharma's Return On Capital Employed Insights ↗

September 28, 2022

According to data from Benzinga Pro, during Q4, Aytu BioPharma's (NASDAQ:AYTU) reported sales totaled $27.45 million. Despite a 66.65% increase in earnings, the company posted a loss of $17.70...

Via Benzinga

Aytu BioPharma Reports Record Fourth Quarter and Fiscal Year 2022 Revenue

September 27, 2022

Via ACCESSWIRE

Aytu BioPharma Announces Addition of Fourth Patent License for AR101/Enzastaurin

September 14, 2022

Via ACCESSWIRE

Aytu BioPharma Announces Issuance of Its First Patent for AR101/Enzastaurin

August 16, 2022

Via ACCESSWIRE

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 27, 2022

Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.

Via Benzinga

Earnings Scheduled For September 27, 2022 ↗

September 27, 2022

Companies Reporting Before The Bell • Ferguson (NYSE:FERG) is projected to report quarterly earnings at $2.79 per share on revenue of $7.86 billion.

Via Benzinga

Aytu BioPharma's Earnings: A Preview ↗

September 26, 2022

Aytu BioPharma (NASDAQ:AYTU) is set to give its latest quarterly earnings report on Tuesday, 2022-09-27. Here's what investors need to know before the announcement. Analysts estimate that Aytu...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 21, 2022

Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million.

Via Benzinga

Aytu BioPharma to Report Fourth Quarter and Fiscal 2022 Financial Results on September 27, 2022

September 20, 2022

Via ACCESSWIRE

Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday ↗

August 30, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 29, 2022

Via Benzinga

Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

August 29, 2022

Gainers Advanced Human Imaging Limited (NASDAQ: AHI) shares jumped 53% to $1.04. Advanced Human Imaging announced Sunday it signed a Master Services Agreement with Estonia-based Activate Health OÜ.

Via Benzinga

Aytu BioPharma to Participate in September 2022 Investor Conferences

August 24, 2022

Via ACCESSWIRE

Aytu BioPharma Announces Closing of $10.0 Million Registered Public Offering

August 15, 2022

Via ACCESSWIRE

Stocks That Hit 52-Week Lows On Wednesday ↗

August 10, 2022

During Wednesday, 52 stocks hit new 52-week lows.

Via Benzinga

Dow Drops Over 100 Points; Verona Pharma Shares Jump ↗

August 09, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 100 points on Tuesday.

Via Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 09, 2022

Via Benzinga

Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session ↗

August 09, 2022

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....

Via Benzinga

Nasdaq Tumbles 1.5%; BBQ Holdings Shares Spike Higher ↗

August 09, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 1.5% on Tuesday.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 09, 2022

On Tuesday, 73 companies hit new 52-week lows.

Via Benzinga

Aytu BioPharma Announces Pricing of Public Offering

August 09, 2022

Via ACCESSWIRE

Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful ↗

August 09, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 09, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

August 09, 2022

We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on today!

Via InvestorPlace

Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket ↗

August 09, 2022

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 69.6% to $1.04 in pre-market trading after Fnu Oudom reported a stake of 44% in the company in 13D.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.